Area of research
Reproductive Medicine · Health, Toxicology and Mutagenesis
Research interest
Research interests include Hypothalamic control of reproductive hormones, Effects and risks of endocrine disrupting chemicals, Neuroendocrine regulation and behavior, and Stress Responses and Cortisol.
The Conflict between Regulatory Agencies over the 20,000-Fold Lowering of the Tolerable Daily Intake (TDI) for Bisphenol A (BPA) by the European Food Safety Authority (EFSA)
Exposure to environmental chemicals and perinatal psychopathology
Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification
Epigenetic impacts of endocrine disruptors in the brain
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
Age and Long-Term Hormone Treatment Effects on the Ultrastructural Morphology of the Median Eminence of Female Rhesus Macaques
G‐protein coupled estrogen receptor, estrogen receptor α, and progesterone receptor immunohistochemistry in the hypothalamus of aging female rhesus macaques given long‐term estradiol treatment
Policy Decisions on Endocrine Disruptors Should Be Based on Science Across Disciplines: A Response to Dietrich et al.
Policy Decisions on Endocrine Disruptors Should Be Based on Science across Disciplines: A Response to Dietrich et al.
Reprint of: Policy decisions on endocrine disruptors should be based on science across disciplines: A response to Dietrich et al.
Policy decisions on endocrine disruptors should be based on science across disciplines
Reprint of: Policy decisions on endocrine disruptors should be based on science across disciplines: A response to Dietrich, et al.
Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich<i>et al</i>.
Endocrine-Disrupting Chemicals and Public Health Protection: A Statement of Principles from The Endocrine Society
Designing endocrine disruption out of the next generation of chemicals